873056-24-7 Usage
Chemical Structure
A complex structure that includes a benzo[b]azepine ring and a carbonyl group.
Physical Appearance
White to off-white solid.
Potential Applications
Pharmaceutical industry as a building block for the synthesis of new drugs.
Functional Groups
Presence of an amino group and a ketone functional group.
Versatility
A versatile intermediate for the production of various organic compounds.
Therapeutic Applications
Potential therapeutic applications.
Industrial Applications
Potential industrial applications.
Value
A valuable chemical with potential therapeutic and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 873056-24-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,0,5 and 6 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 873056-24:
(8*8)+(7*7)+(6*3)+(5*0)+(4*5)+(3*6)+(2*2)+(1*4)=177
177 % 10 = 7
So 873056-24-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H16N2O/c1-9(15)14-7-3-2-4-10-5-6-11(13)8-12(10)14/h5-6,8H,2-4,7,13H2,1H3
873056-24-7Relevant articles and documents
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
